Arrowhead Pharmaceuticals, Inc. (ARWR)
NASDAQ: ARWR · Real-Time Price · USD
74.81
+1.33 (1.81%)
At close: May 1, 2026, 4:00 PM EDT
74.80
-0.01 (-0.01%)
After-hours: May 1, 2026, 6:46 PM EDT
Arrowhead Pharmaceuticals Stock Forecast
Stock Price Forecast
The 11 analysts that cover Arrowhead Pharmaceuticals stock have a consensus rating of "Strong Buy" and an average price target of $83.82, which forecasts a 12.04% increase in the stock price over the next year. The lowest target is $17 and the highest is $110.
Price Target: $83.82 (+12.04%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Arrowhead Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 6 | 6 | 5 | 5 | 5 |
| Buy | 2 | 2 | 2 | 2 | 3 | 4 |
| Hold | 3 | 3 | 3 | 3 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 11 | 11 | 10 | 10 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JP Morgan | JP Morgan | Buy Initiates $88 | Buy | Initiates | $88 | +17.63% | May 1, 2026 |
| Morgan Stanley | Morgan Stanley | Hold → Buy Upgrades $78 → $100 | Hold → Buy | Upgrades | $78 → $100 | +33.67% | Apr 21, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $100 | Strong Buy | Reiterates | $100 | +33.67% | Mar 25, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $100 | Strong Buy | Reiterates | $100 | +33.67% | Feb 10, 2026 |
| B. Riley Securities | B. Riley Securities | Strong Buy Maintains $61 → $101 | Strong Buy | Maintains | $61 → $101 | +35.01% | Jan 22, 2026 |
Financial Forecast
Revenue This Year
460.20M
from 829.45M
Decreased by -44.52%
Revenue Next Year
327.83M
from 460.20M
Decreased by -28.76%
EPS This Year
-3.53
from -0.01
EPS Next Year
-4.28
from -3.53
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 672.0M | 501.9M | ||||||
| Avg | 460.2M | 327.8M | ||||||
| Low | 306.7M | 111.9M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | -19.0% | 9.1% | ||||||
| Avg | -44.5% | -28.8% | ||||||
| Low | -63.0% | -75.7% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | -2.70 | -1.69 | ||||||
| Avg | -3.53 | -4.28 | ||||||
| Low | -4.36 | -6.57 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | - | - | ||||||
| Avg | - | - | ||||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.